Picture of Cansino Biologics logo

6185 Cansino Biologics News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: CanSino Biologics Inc Sees FY Net Loss Attributable RMB335.0 Mln To RMB385.0 Mln

Jan 17 (Reuters) - CanSino Biologics Inc  688185.SS :
    * SEES NET LOSS ATTRIBUTABLE FOR YEAR TO BE RMB335.0 MILLION
TO
RMB385.0 MILLION
    * SEES REVENUE OF RMB825.0 MILLION TO RMB865.0 MILLION FOR
YEAR


Further company coverage:  688185.SS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cansino Biologics

See all news